Search
for
Sort by
Research 481–510 of 1000+
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Expression of CD117 and platelet-derived growth factor receptor α in patients with alopecia areata
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Serum Vitamin D levels and Alopecia areata- A hospital based case-control study from North-India
- The Gut-Scalp Axis: A Systematic Review of Dietary Interventions on Microbiome Dysbiosis in Scalp Disorders
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Dermoscopy of alopecia areata in restrospective analysis
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- A study of serum prolactin in dermatological diseases in a tertiary care hospital of Assam
- Platelet-Rich Plasma for Androgenetic Alopecia in Women: A Single-Center Case Series Study in Qatar
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Genomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Step-down approach to concentration of intra-lesional triamcinolone acetonide in treatment of scalp patchy alopecia areata: insights from an open-label randomized trial
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- Effects of age and sex on the comorbidities of alopecia areata: A cross‐sectional hospital‐based study
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses